Funding Calls

In 2015, the NIH launched the “4D Nucleome” (4DN) Common Fund Program that aims to understand the principles underlying nuclear organization in space and time, the role nuclear organization plays in gene expression and cellular function, and how changes in nuclear organization affect normal development as well as various diseases.  The initial phase of the 4DN Program includes five years of support for twenty-nine Cooperative Agreement awards and ten smaller two-year projects. 4DN data, reagents, software and tools are shared with the larger scientific community through the 4DN community portal.

The NIH has issued six Funding Opportunity Announcements for the 4D Nucleome program. Some of these are open to applicants outside of the US, or to applications with partners outside of the US.

The Agence Nationale de la Recherche (ANR), the Bundesministerium für Bildung und Forschung (BMBF) and the Canadian Institutes of Health Research (CIHR) together with the Fonds de Recherche du Québec - Santé (FRQS) are launching a multilateral joint transnational call for proposals to support epigenomics of common and complex diseases. The call aims to promote and create strategic synergy and multidisciplinary research activities between scientists in France, Germany and Canada. Only transnational projects from academia, clinical/public health sector and enterprise will be funded.

European Commission has published the first work programme and calls for the health, demographic change and wellbeing challenge societal challenge of Horizon 2020 for 2014/15 a few days ago. Horizon 2020 is the EU Research and Innovation programme with nearly €80 billion of funding available (€7 billion for Health) over 7 years (2014 to 2020).

The Agence Nationale de la Recherche (ANR) is joining the BMBF (Bundesministerium für Bildung und Forschung – German ministry for education and research) to launch a joint call which aims to promote synergy and added value through the establishment of high-quality, interdisciplinary binational collaborations among researchers in France and Germany, in the field of human epigenomics.

The Funding Opportunity Announcement (FAO) seeks proposals to develop novel tools and technologies for tissue-, cell-, or locus-specific manipulation of the epigenome. Proposals may also develop tools and technologies to enable epigenetic manipulation with precise temporal control. Also investigators at foreign institutions are eligible to apply.